Connecting the dots: (RANKL<sup>+</sup>) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancer.

Transl Lung Cancer Res · 2025 · PMC12000961 · PMID 40248741

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, likely owing to the limited sample sizes, inclusion of non-treatment-naive patients, and obtaining samples during osimertinib treatment, this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Connecting the dots: (RANKL&lt;sup&gt;+&lt;/sup&gt;) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancer.

The sentences

Connecting the dots: (RANKL<sup>+</sup>) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancer.